Original article
Treatment of symptomatic epiblepharon with Botulinum toxin type A in patients under 2 years of age
Experiencia del uso de la toxina botulínica tipo A para el tratamiento sintomático del epiblefaron en pacientes menores de 2 años
Y. de la Fuente Díez
, O. Olvera Morales, C.Y. Chen López, J.L. Tovilla Canales, A. Nava Castañeda
Corresponding author
Departamento de Órbita y Oculoplástica, Instituto Oftalmológico Conde de Valenciana (I.A.P.), Mexico City, CDMX, Mexico
Read
2461
Timeswas read the article
47
Total PDF
2414
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 173 | 1 | 174 |
| 2025 9 | 173 | 3 | 176 |
| 2025 8 | 148 | 7 | 155 |
| 2025 7 | 91 | 0 | 91 |
| 2025 6 | 95 | 0 | 95 |
| 2025 5 | 101 | 2 | 103 |
| 2025 4 | 84 | 3 | 87 |
| 2025 3 | 63 | 2 | 65 |
| 2025 2 | 35 | 0 | 35 |
| 2025 1 | 88 | 1 | 89 |
| 2024 12 | 58 | 2 | 60 |
| 2024 11 | 39 | 0 | 39 |
| 2024 10 | 36 | 0 | 36 |
| 2024 9 | 34 | 0 | 34 |
| 2024 8 | 39 | 3 | 42 |
| 2024 7 | 20 | 2 | 22 |
| 2024 6 | 24 | 0 | 24 |
| 2024 5 | 37 | 3 | 40 |
| 2024 4 | 26 | 2 | 28 |
| 2024 3 | 27 | 0 | 27 |
| 2024 2 | 46 | 0 | 46 |
| 2024 1 | 55 | 0 | 55 |
| 2023 12 | 52 | 0 | 52 |
| 2023 11 | 80 | 0 | 80 |
| 2023 10 | 60 | 0 | 60 |
| 2023 9 | 39 | 0 | 39 |
| 2023 8 | 38 | 0 | 38 |
| 2023 7 | 32 | 0 | 32 |
| 2023 6 | 51 | 1 | 52 |
| 2023 5 | 47 | 6 | 53 |
| 2023 4 | 40 | 0 | 40 |
| 2023 3 | 52 | 1 | 53 |
| 2023 2 | 37 | 0 | 37 |
| 2023 1 | 36 | 0 | 36 |
| 2022 12 | 42 | 2 | 44 |
| 2022 11 | 31 | 0 | 31 |
| 2022 10 | 33 | 0 | 33 |
| 2022 9 | 38 | 0 | 38 |
| 2022 8 | 41 | 4 | 45 |
| 2022 7 | 32 | 2 | 34 |
| 2022 6 | 27 | 0 | 27 |
| 2022 5 | 21 | 0 | 21 |
| 2022 4 | 20 | 0 | 20 |
| 2022 3 | 23 | 0 | 23 |
| 2022 2 | 27 | 0 | 27 |
| 2022 1 | 20 | 0 | 20 |
| 2021 12 | 2 | 0 | 2 |
| 2021 11 | 1 | 0 | 1 |
Show all
